AUTOLUS THERAPEUTICS PLC (AUTL) Stock Cash Flow
NASDAQ:AUTL - Nasdaq - US05280R1005 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -220.66M | -208.38M | -148.84M | -142.10M | -142.09M | |||
| Depreciation Amortization | 7.72M | 6.57M | 7.42M | 8.46M | 5.66M | |||
| Income Taxes - Deferred | -185.00K | -986.00K | -270.00K | -70.00K | -1.34M | |||
| Change In Working Capital | -23.66M | 292.00K | 3.97M | 4.14M | 1.41M | |||
| Taxes Paid | 2.39M | 551.00K | 470.00K | 360.00K | 1.84M | |||
| Other non cash items | 30.52M | 56.92M | 25.41M | 11.71M | 18.61M | |||
| OPERATING CASH FLOW | -206.27M | -145.59M | -112.31M | -117.86M | -117.76M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -34.82M | -10.99M | -10.84M | -8.86M | -14.68M | |||
| Other Investing Activity | -359.73M | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -394.55M | -10.99M | -10.84M | -8.86M | -14.68M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 70.00M | 0.00 | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 550.58M | 27.00K | 163.97M | 246.03M | 74.42M | |||
| Other Financing Activity | -31.02M | -910.00K | 59.64M | 38.04M | N/A | |||
| FINANCING CASH FLOW | 589.55M | -883.00K | 223.61M | 284.06M | 74.42M | |||
| Exchange Rate Effect | -261.00K | 15.03M | -28.38M | -750.00K | 680.00K | |||
| CHANGE IN CASH | -11.53M | -142.43M | 72.08M | 156.59M | -57.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -206.27M | -145.59M | -112.31M | -117.86M | -117.76M | |||
| Capital Expenditure | -34.82M | -10.99M | -10.84M | -8.86M | -14.68M | |||
| FREE CASH FLOW | -241.09M | -156.57M | -123.15M | -126.72M | -132.44M | |||
All data in USD